Combination Targeted Therapy Without Chemotherapy Viable for HER2-Positive Breast Cancer Patients
News
A new Phase II clinical trial showed encouraging results for the targeted therapy of trastuzumab with lapatinib, instead of chemotherapy, for the treatment of breast cancer patients with HER-2 and estrogen positive ... Read more